Krsnaa Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 147.16 Cr
as on 15-12-2024
- Paid Up Capital ₹ 16.14 Cr
as on 15-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 221.16 Cr
as on 15-12-2024
- Satisfied Charges ₹ 319.95 Cr
as on 15-12-2024
About Krsnaa Diagnostics
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543328 and on the National Stock Exchange(NSE) under KRSNAA.
The Corporate was formerly known as Krsna Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 147.16 Cr and a paid-up capital of Rs 16.14 Cr.
The company currently has active open charges totaling ₹221.16 Cr. The company has closed loans amounting to ₹319.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Krsnaa Diagnostics Limited India are Pawan Daga as CFO and Sujoy Bose as Company Secretary. Adesh Kumar, Chetan Desai, Chhaya Palrecha, and Five other members serve as directors at the Company.
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Krsnaa Diagnostics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pawan Daga | CFO | 18-Jan-2021 | Current |
Sujoy Bose  | Company Secretary | 07-Sep-2023 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yash Mutha | Whole-Time Director | 31-Jan-2019 | Current |
| Prem Pradeep | Nominee Director | 08-Oct-2020 | Current |
| Pallavi Bhatevara | Whole-Time Director | 01-Apr-2024 | Current |
| Chetan Desai | Director | 25-Apr-2021 | Current |
| Adesh Kumar | Director | 28-May-2022 | Current |
| Chhaya Palrecha | Director | 25-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Krsnaa Diagnostics.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Krsnaa Diagnostics?
Unlock access to Krsnaa Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Universal Sompo General Insurance Company LimitedActive 17 years 11 monthsChhaya Palrecha is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 21 Feb 2024 | ₹23.75 Cr | Open |
Others Creation Date: 26 Aug 2023 | ₹52.00 Cr | Open |
State Bank Of India Creation Date: 12 Sep 2022 | ₹30.00 Cr | Open |
How Many Employees Work at Krsnaa Diagnostics?
Unlock and access historical data on people associated with Krsnaa Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krsnaa Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krsnaa Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
